Mirum Pharmaceuticals Cash from Investing (TTM) Insights

Mirum Pharmaceuticals Inc (MIRM)

25.11 +0.04 (+0.16%) USD | NASDAQ | Apr 30, 16:00

25.11 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	-107.20M
September 30, 2023	-78.44M
June 30, 2023	24.79M
March 31, 2023	13.22M
December 31, 2022	7.70M
September 30, 2022	88.96M
June 30, 2022	166.26M
March 31, 2022	117.83M
December 31, 2021	48.55M

Date	Value
September 30, 2021	-64.42M
June 30, 2021	-81.10M
March 31, 2021	-28.67M
December 31, 2020	37.87M
September 30, 2020	37.68M
June 30, 2020	-7.602M
March 31, 2020	-93.98M
December 31, 2019	-127.78M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-127.78M

Minimum

Dec 2019

166.26M

Maximum

Jun 2022

-2.726M

Average

7.70M

Median

Dec 2022

Cash from Investing (TTM) Benchmarks